- Home
- TTNP vs XXII Comparison
TTNP vs XXII Comparison
Compare TTNP & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- XXII
- Stock Information
- Founded
- TTNP 1991
- XXII 1998
- Country
- TTNP United States
- XXII United States
- Employees
- TTNP N/A
- XXII N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- XXII Medicinal Chemicals and Botanical Products
- Sector
- TTNP Health Care
- XXII Health Care
- Exchange
- TTNP Nasdaq
- XXII Nasdaq
- Market Cap
- TTNP 3.0M
- XXII 2.8M
- IPO Year
- TTNP 1996
- XXII N/A
- Fundamental
- Price
- TTNP $3.79
- XXII $5.10
- Analyst Decision
- TTNP
- XXII
- Analyst Count
- TTNP 0
- XXII 0
- Target Price
- TTNP N/A
- XXII N/A
- AVG Volume (30 Days)
- TTNP 41.9K
- XXII 2.5M
- Earning Date
- TTNP 01-03-2025
- XXII 11-12-2024
- Dividend Yield
- TTNP N/A
- XXII N/A
- EPS Growth
- TTNP N/A
- XXII N/A
- EPS
- TTNP N/A
- XXII N/A
- Revenue
- TTNP N/A
- XXII $17,304,000.00
- Revenue This Year
- TTNP N/A
- XXII $56.94
- Revenue Next Year
- TTNP N/A
- XXII $2.98
- P/E Ratio
- TTNP N/A
- XXII N/A
- Revenue Growth
- TTNP N/A
- XXII N/A
- 52 Week Low
- TTNP $3.03
- XXII $3.90
- 52 Week High
- TTNP $14.80
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- TTNP 48.54
- XXII 41.23
- Support Level
- TTNP $3.14
- XXII $4.80
- Resistance Level
- TTNP $3.38
- XXII $12.49
- Average True Range (ATR)
- TTNP 0.22
- XXII 2.00
- MACD
- TTNP 0.02
- XXII 0.36
- Stochastic Oscillator
- TTNP 52.24
- XXII 3.90
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.